6 ways India can strengthen oversight around IV glutathione and injectable cosmetics |
Opinion National Interest PoV 50-Word Edit
ThePrint On Camera Videos In Pictures
Society & Culture Around Town Book Excerpts Vigyapanti The Dating Story
More Judiciary Education YourTurn Work With Us Campus Voice
Opinion National Interest PoV 50-Word Edit
ThePrint On Camera Videos In Pictures
Society & Culture Around Town Book Excerpts Vigyapanti The Dating Story
More Judiciary Education YourTurn Work With Us Campus Voice
6 ways India can strengthen oversight around IV glutathione and injectable cosmetics
Rampant quackery forces Indian regulators to impose restrictions on legitimate therapies. The same pattern is now repeating with glutathione.
India has earned global respect as the pharmacy of the world. Its pharmaceutical industry supplies affordable, high-quality medicines to millions across continents. It’s a symbol of the nation’s scientific capability.
Having visited world-class facilities such as the Tirupati Group’s manufacturing unit in Paonta Sahib and the Forest Essentials plant near Rishikesh, I have personally witnessed India’s ability to uphold international standards when science, ethics, and strict quality control converge.
Aesthetic and cosmetic medicine is expanding at an extraordinary pace in India—from advanced dermatology clinics and anti-ageing therapies to injectables, lasers, regenerative medicine, and cutting-edge skin treatments. Rising consumer awareness, technological progress, and greater acceptance of cosmetic procedures have created a booming sector with immense economic and medical potential.
India has every capability to become a global leader in aesthetic medicine. But unregulated growth is proving dangerous.
A recent advisory by the Central Drugs Standard Control Organisation (CDSCO) has clarified that cosmetic products supplied in injectable form do not fall under the definition of cosmetics and are not permitted for use by consumers, professionals, or aesthetic clinics. The National Medical Commission guidelines also state that cosmetic and aesthetic procedures should be performed only by qualified dermatologists, plastic surgeons, and trained aesthetic physicians.
However, enforcement remains inconsistent. In Delhi, invasive procedures........